{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:41:56Z","timestamp":1790516516772,"version":"4.1.0"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2013,8,14]],"date-time":"2013-08-14T00:00:00Z","timestamp":1376438400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0071900","type":"journal-article","created":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T02:32:28Z","timestamp":1376533948000},"page":"e71900","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Myostatin and Insulin-Like Growth Factor I: Potential Therapeutic Biomarkers for Pompe Disease"],"prefix":"10.1371","volume":"8","author":[{"given":"Yin-Hsiu","family":"Chien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Der-Sheng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuh-Liang","family":"Hwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth L.","family":"Thurberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Shiung","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,8,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/labinvest.3700484","article-title":"Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease","volume":"86","author":"BL Thurberg","year":"2006","journal-title":"Lab Invest"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","article-title":"Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease","volume":"68","author":"PS Kishnani","year":"2007","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/GIM.0b013e31819d0996","article-title":"Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease","volume":"11","author":"M Nicolino","year":"2009","journal-title":"Genet Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e1116","DOI":"10.1542\/peds.2008-3667","article-title":"Pompe disease in infants: improving the prognosis by newborn screening and early treatment","volume":"124","author":"YH Chien","year":"2009","journal-title":"Pediatrics"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","article-title":"A randomized study of alglucosidase alfa in late-onset Pompe&apos;s disease","volume":"362","author":"AT van der Ploeg","year":"2010","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","article-title":"Pompe disease diagnosis and management guideline","volume":"8","author":"PS Kishnani","year":"2006","journal-title":"Genet Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/GIM.0b013e3181a87867","article-title":"Long-term monitoring of patients with infantile-onset Pompe disease on enzyme replacement therapy using a urinary glucose tetrasaccharide biomarker","volume":"11","author":"SP Young","year":"2009","journal-title":"Genet Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1096\/fj.06-7690com","article-title":"Local expression of IGF-1 accelerates muscle regeneration by rapidly modulating inflammatory cytokines and chemokines","volume":"21","author":"L Pelosi","year":"2007","journal-title":"FASEB J"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.cardiores.2005.06.028","article-title":"Insulin-like growth factor-1 mediates stretch-induced upregulation of myostatin expression in neonatal rat cardiomyocytes","volume":"68","author":"KG Shyu","year":"2005","journal-title":"Cardiovasc Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1136\/bjsm.2007.045518","article-title":"Response of growth and myogenic factors in human skeletal muscle to strength training","volume":"42","author":"Y Liu","year":"2008","journal-title":"Br J Sports Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/387083a0","article-title":"Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member","volume":"387","author":"AC McPherron","year":"1997","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.domaniend.2003.10.001","article-title":"Nutrient supply enhances both IGF-I and MSTN mRNA levels in chicken skeletal muscle","volume":"26","author":"A Guernec","year":"2004","journal-title":"Domest Anim Endocrinol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1365-2265.2011.04120.x","article-title":"Serum myostatin levels and grip strength in normal subjects and patients on maintenance haemodialysis","volume":"75","author":"DS Han","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.cca.2012.04.023","article-title":"Plasma myostatin measured by a competitive ELISA using a highly specific antiserum","volume":"413","author":"KF Wintgens","year":"2012","journal-title":"Clin Chim Acta"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000334643","article-title":"A novel GH1 mutation in a family with isolated growth hormone deficiency type II","volume":"77","author":"Z Gucev","year":"2012","journal-title":"Horm Res Paediatr"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1073\/pnas.0709144105","article-title":"Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors","volume":"105","author":"AM Haidet","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-1759(94)90136-8","article-title":"Extension of the four-parameter logistic model for ELISA to multianalyte analysis","volume":"177","author":"G Jones","year":"1994","journal-title":"Jl Immunol Methods"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/002215540505300108","article-title":"High-resolution light microscopy (HRLM) and digital analysis of Pompe disease pathology","volume":"53","author":"CM Lynch","year":"2005","journal-title":"J Histochem Cytochem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-4652(200004)183:1<1::AID-JCP1>3.0.CO;2-J","article-title":"Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis","volume":"183","author":"A Grimberg","year":"2000","journal-title":"J Cell Physiol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1083\/jcb.200108071","article-title":"Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice","volume":"157","author":"ER Barton","year":"2002","journal-title":"J Cell Biol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1083\/jcb.200407021","article-title":"Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model","volume":"168","author":"G Dobrowolny","year":"2005","journal-title":"J Cell Biol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0378-3782(86)90096-4","article-title":"Circulating insulin-like growth factor I levels in newborn premature and full-term infants followed longitudinally","volume":"13","author":"JD Lineham","year":"1986","journal-title":"Early Hum Dev"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ghir.2008.01.008","article-title":"Reference values of IGF-I in children from birth to 5 years of age, in Burkina Faso, using blood samples on filter paper","volume":"18","author":"S Kouanda","year":"2008","journal-title":"Growth Horm IGF Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4274\/jcrpe.v3i2.17","article-title":"Serum IGF-1 and IGFBP-3 levels in healthy children between 0 and 6 years of age","volume":"3","author":"B Y\u00fcksel","year":"2011","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cardiores.2005.09.007","article-title":"Myostatin, the cardiac chalone of insulin-like growth factor-1","volume":"68","author":"V Gaussin","year":"2005","journal-title":"Cardiovasc Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1542\/peds.113.5.e448","article-title":"Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk","volume":"113","author":"JM Van den Hout","year":"2004","journal-title":"Pediatrics"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/mt.2010.110","article-title":"Evaluation of systemic follistatin as an adjuvant to stimulate muscle repair and improve motor function in Pompe mice","volume":"18","author":"JW Foley","year":"2010","journal-title":"Mol Ther"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"8282","DOI":"10.1073\/pnas.84.23.8282","article-title":"Isolation and partial characterization of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone","volume":"84","author":"N Ueno","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1210\/jc.2008-2005","article-title":"Role of follistatin in promoting adipogenesis in women","volume":"94","author":"JN Flanagan","year":"2009","journal-title":"J Clin Endocrinol Metabol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3109\/1354750X.2010.495786","article-title":"Follistatin as a potent regulator of bone metabolism","volume":"15","author":"A Gajos-Michniewicz","year":"2010","journal-title":"Biomarkers"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.2047-6310.2011.00004.x","article-title":"Circulating follistatin in the human foetus at term birth","volume":"7","author":"G Sebastiani","year":"2012","journal-title":"Pediatr Obes"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0071900","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T19:17:38Z","timestamp":1540322258000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0071900"}},"subtitle":[],"editor":[{"given":"Alejandro","family":"Lucia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,8,14]]},"references-count":31,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0071900","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,14]]}}}